| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-017-15154-6 |
| P8608 | Fatcat ID | release_x3f5ynf2knfttbq2j4u3rjkk5e |
| P932 | PMC publication ID | 5688117 |
| P698 | PubMed publication ID | 29142285 |
| P50 | author | Reilly Enos | Q42780518 |
| Mitra S Ganewatta | Q60168725 | ||
| P2093 | author name string | Mitzi Nagarkatti | |
| Prakash Nagarkatti | |||
| E Angela Murphy | |||
| Kandy T Velazquez | |||
| Chuanbing Tang | |||
| Pegah Mehrpouya-Bahrami | |||
| Kumaraswamy Naidu Chitrala | |||
| Jamie McCellan | |||
| P2860 | cites work | Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 |
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| Metagenomic analysis of the human distal gut microbiome | Q24633486 | ||
| Activation of the peripheral endocannabinoid system in human obesity | Q24655297 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| Leptin-regulated endocannabinoids are involved in maintaining food intake | Q28211969 | ||
| CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity | Q28242954 | ||
| Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism | Q28573389 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| The gut microbiota shapes intestinal immune responses during health and disease | Q29547727 | ||
| Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity | Q29615051 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells | Q44265469 | ||
| CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans. | Q45908497 | ||
| The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. | Q46213429 | ||
| The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance | Q46595047 | ||
| Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production | Q48145978 | ||
| Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. | Q51771968 | ||
| Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. | Q54468190 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| Richness of human gut microbiome correlates with metabolic markers | Q29617365 | ||
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 | ||
| Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome | Q29617424 | ||
| Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. | Q30962119 | ||
| Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography | Q33224612 | ||
| An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform | Q34039945 | ||
| The endocannabinoid system links gut microbiota to adipogenesis | Q34078880 | ||
| Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. | Q34093446 | ||
| Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing | Q34440704 | ||
| Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation | Q34463631 | ||
| Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling | Q34491604 | ||
| Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial | Q34494637 | ||
| Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis | Q35034704 | ||
| Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
| Reducing the dietary omega-6:omega-3 utilizing α-linolenic acid; not a sufficient therapy for attenuating high-fat-diet-induced obesity development nor related detrimental metabolic and adipose tissue inflammatory outcomes | Q35148099 | ||
| Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. | Q35157719 | ||
| Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice | Q35405358 | ||
| Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome | Q35570155 | ||
| Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? | Q35725309 | ||
| Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity | Q35738935 | ||
| Cannabinoid-based drugs as anti-inflammatory therapeutics | Q36111923 | ||
| Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes | Q36373581 | ||
| Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn | Q36377155 | ||
| Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase | Q36377312 | ||
| Host remodeling of the gut microbiome and metabolic changes during pregnancy | Q36421887 | ||
| Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice | Q36658938 | ||
| Microbial metabolite butyrate facilitates M2 macrophage polarization and function | Q36814971 | ||
| Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding | Q37376946 | ||
| Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity | Q37551092 | ||
| Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. | Q37695058 | ||
| Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis | Q37855523 | ||
| Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model. | Q38939502 | ||
| Chylomicrons promote intestinal absorption of lipopolysaccharides | Q39936075 | ||
| Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways | Q40197858 | ||
| Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor | Q40638952 | ||
| The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. | Q42090677 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| ImageJ | Q1659584 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CNR2 | Q17907844 |
| cannabinoid receptor | Q421237 | ||
| cannabinoids | Q422936 | ||
| P304 | page(s) | 15645 | |
| P577 | publication date | 2017-11-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity | |
| P478 | volume | 7 |
| Q64263349 | Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells |
| Q92401471 | Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases |
| Q91934280 | Cannabinoids and the expanded endocannabinoid system in neurological disorders |
| Q92478893 | Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment |
| Q58695140 | Falcarinol Is a Potent Inducer of Heme Oxygenase-1 and Was More Effective than Sulforaphane in Attenuating Intestinal Inflammation at Diet-Achievable Doses |
| Q98177611 | Investigating the Mechanistic Differences of Obesity-Inducing Lactobacillus kefiranofaciens M1 and Anti-obesity Lactobacillus mali APS1 by Microbolomics and Metabolomics |
| Q92753123 | Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome |
| Q89509774 | Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors |
| Q57165498 | New approaches and challenges to targeting the endocannabinoid system |
| Q89920189 | Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators |
| Q90479312 | Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol |
| Q89964094 | Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs |
| Q92058518 | Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice |
| Q61803411 | Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota |
| Q92613057 | Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity |
| Q92435620 | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms |
Search more.